Frontlight ResearchEarly access
Trial site
Cancer Hospital Affiliated to Xinjiang Medical University
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer4 trials
- Metastatic breast cancer2 trials
- Follicular lymphoma1 trial
- Lung cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Shanghai Junshi Bioscience Co., Ltd.2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Hutchison Medipharma Limited1 trial
- Jazz Pharmaceuticals1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Active, not recruiting
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026